Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing: comparative genomics associated with differential virulence.

Sahl JW, Allender CJ, Colman RE, Califf KJ, Schupp JM, Currie BJ, Van Zandt KE, Gelhaus HC, Keim P, Tuanyok A.

PLoS One. 2015 Mar 24;10(3):e0121052. doi: 10.1371/journal.pone.0121052. eCollection 2015.

2.

Colony Morphology Variation of Burkholderia pseudomallei Is Associated with Antigenic Variation and O-Polysaccharide Modification.

Wikraiphat C, Saiprom N, Tandhavanant S, Heiss C, Azadi P, Wongsuvan G, Tuanyok A, Holden MT, Burtnick MN, Brett PJ, Peacock SJ, Chantratita N.

Infect Immun. 2015 May;83(5):2127-38. doi: 10.1128/IAI.02785-14. Epub 2015 Mar 16.

PMID:
25776750
3.

A Burkholderia pseudomallei colony variant necessary for gastric colonization.

Austin CR, Goodyear AW, Bartek IL, Stewart A, Sutherland MD, Silva EB, Zweifel A, Vitko NP, Tuanyok A, Highnam G, Mittelman D, Keim P, Schweizer HP, Vázquez-Torres A, Dow SW, Voskuil MI.

MBio. 2015 Feb 3;6(1). pii: e02462-14. doi: 10.1128/mBio.02462-14.

4.

Melioidosis diagnostic workshop, 2013.

Hoffmaster AR, AuCoin D, Baccam P, Baggett HC, Baird R, Bhengsri S, Blaney DD, Brett PJ, Brooks TJ, Brown KA, Chantratita N, Cheng AC, Dance DA, Decuypere S, Defenbaugh D, Gee JE, Houghton R, Jorakate P, Lertmemongkolchai G, Limmathurotsakul D, Merlin TL, Mukhopadhyay C, Norton R, Peacock SJ, Rolim DB, Simpson AJ, Steinmetz I, Stoddard RA, Stokes MM, Sue D, Tuanyok A, Whistler T, Wuthiekanun V, Walke HT.

Emerg Infect Dis. 2015 Feb;21(2). doi: 10.3201/eid2102.141045.

5.

Whole-genome sequencing of Burkholderia pseudomallei isolates from an unusual melioidosis case identifies a polyclonal infection with the same multilocus sequence type.

Price EP, Sarovich DS, Viberg L, Mayo M, Kaestli M, Tuanyok A, Foster JT, Keim P, Pearson T, Currie BJ.

J Clin Microbiol. 2015 Jan;53(1):282-6. doi: 10.1128/JCM.02560-14. Epub 2014 Oct 22.

PMID:
25339397
6.

Burkholderia pseudomallei type G in Western Hemisphere.

Gee JE, Allender CJ, Tuanyok A, Elrod MG, Hoffmaster AR.

Emerg Infect Dis. 2014 Apr;20(4):682-4. doi: 10.3201/eid2004.130960.

7.

Variable virulence factors in Burkholderia pseudomallei (melioidosis) associated with human disease.

Sarovich DS, Price EP, Webb JR, Ward LM, Voutsinos MY, Tuanyok A, Mayo M, Kaestli M, Currie BJ.

PLoS One. 2014 Mar 11;9(3):e91682. doi: 10.1371/journal.pone.0091682. eCollection 2014.

8.

Structural characterization of polysaccharides expressed by Burkholderia oklahomensis E0147.

Stone JK, Heiss C, Wang Z, Black I, Grasso SA, Koppisch AT, Azadi P, Keim P, Tuanyok A.

Carbohydr Res. 2014 Mar 11;386:68-72. doi: 10.1016/j.carres.2013.08.011. Epub 2013 Aug 25.

PMID:
24491843
9.

Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides.

Podin Y, Sarovich DS, Price EP, Kaestli M, Mayo M, Hii K, Ngian H, Wong S, Wong I, Wong J, Mohan A, Ooi M, Fam T, Wong J, Tuanyok A, Keim P, Giffard PM, Currie BJ.

Antimicrob Agents Chemother. 2014;58(1):162-6. doi: 10.1128/AAC.01842-13. Epub 2013 Oct 21.

10.

Complete Genome Sequence of the Encephalomyelitic Burkholderia pseudomallei Strain MSHR305.

Stone JK, Johnson SL, Bruce DC, Detter JC, Mayo M, Currie BJ, Gelhaus HC, Keim P, Tuanyok A.

Genome Announc. 2013 Aug 22;1(4). pii: e00656-13. doi: 10.1128/genomeA.00656-13.

11.

Accurate and rapid identification of the Burkholderia pseudomallei near-neighbour, Burkholderia ubonensis, using real-time PCR.

Price EP, Sarovich DS, Webb JR, Ginther JL, Mayo M, Cook JM, Seymour ML, Kaestli M, Theobald V, Hall CM, Busch JD, Foster JT, Keim P, Wagner DM, Tuanyok A, Pearson T, Currie BJ.

PLoS One. 2013 Aug 13;8(8):e71647. doi: 10.1371/journal.pone.0071647. eCollection 2013.

12.

Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection.

Price EP, Sarovich DS, Mayo M, Tuanyok A, Drees KP, Kaestli M, Beckstrom-Sternberg SM, Babic-Sternberg JS, Kidd TJ, Bell SC, Keim P, Pearson T, Currie BJ.

MBio. 2013 Jul 16;4(4). pii: e00388-13. doi: 10.1128/mBio.00388-13.

13.

Genome Sequence of Burkholderia pseudomallei NCTC 13392.

Sahl JW, Stone JK, Gelhaus HC, Warren RL, Cruttwell CJ, Funnell SG, Keim P, Tuanyok A.

Genome Announc. 2013 May 23;1(3). pii: e00183-13. doi: 10.1128/genomeA.00183-13.

14.

Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei.

Limmathurotsakul D, Dance DA, Wuthiekanun V, Kaestli M, Mayo M, Warner J, Wagner DM, Tuanyok A, Wertheim H, Yoke Cheng T, Mukhopadhyay C, Puthucheary S, Day NP, Steinmetz I, Currie BJ, Peacock SJ.

PLoS Negl Trop Dis. 2013;7(3):e2105. doi: 10.1371/journal.pntd.0002105. Epub 2013 Mar 21. Review.

15.

Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor species.

Stone JK, Mayo M, Grasso SA, Ginther JL, Warrington SD, Allender CJ, Doyle A, Georgia S, Kaestli M, Broomall SM, Karavis MA, Insalaco JM, Hubbard KS, McNew LA, Gibbons HS, Currie BJ, Keim P, Tuanyok A.

BMC Microbiol. 2012 Nov 5;12:250. doi: 10.1186/1471-2180-12-250.

16.

An objective approach for Burkholderia pseudomallei strain selection as challenge material for medical countermeasures efficacy testing.

Van Zandt KE, Tuanyok A, Keim PS, Warren RL, Gelhaus HC.

Front Cell Infect Microbiol. 2012 Sep 26;2:120. doi: 10.3389/fcimb.2012.00120. eCollection 2012. Review.

17.

Development and validation of Burkholderia pseudomallei-specific real-time PCR assays for clinical, environmental or forensic detection applications.

Price EP, Dale JL, Cook JM, Sarovich DS, Seymour ML, Ginther JL, Kaufman EL, Beckstrom-Sternberg SM, Mayo M, Kaestli M, Glass MB, Gee JE, Wuthiekanun V, Warner JM, Baker A, Foster JT, Tan P, Tuanyok A, Limmathurotsakul D, Peacock SJ, Currie BJ, Wagner DM, Keim P, Pearson T.

PLoS One. 2012;7(5):e37723. doi: 10.1371/journal.pone.0037723. Epub 2012 May 18.

18.

Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens.

Kaestli M, Richardson LJ, Colman RE, Tuanyok A, Price EP, Bowers JR, Mayo M, Kelley E, Seymour ML, Sarovich DS, Pearson T, Engelthaler DM, Wagner DM, Keim PS, Schupp JM, Currie BJ.

J Clin Microbiol. 2012 Jun;50(6):2059-62. doi: 10.1128/JCM.06737-11. Epub 2012 Mar 21.

19.

The toxin/immunity network of Burkholderia pseudomallei contact-dependent growth inhibition (CDI) systems.

Nikolakakis K, Amber S, Wilbur JS, Diner EJ, Aoki SK, Poole SJ, Tuanyok A, Keim PS, Peacock S, Hayes CS, Low DA.

Mol Microbiol. 2012 May;84(3):516-29. doi: 10.1111/j.1365-2958.2012.08039.x. Epub 2012 Apr 4.

20.

Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.

Sarovich DS, Price EP, Von Schulze AT, Cook JM, Mayo M, Watson LM, Richardson L, Seymour ML, Tuanyok A, Engelthaler DM, Pearson T, Peacock SJ, Currie BJ, Keim P, Wagner DM.

PLoS One. 2012;7(2):e30789. doi: 10.1371/journal.pone.0030789. Epub 2012 Feb 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk